We performed kinetic studies to understand viral entry, proviral integration, and expression of the viral protein Tax
We performed kinetic studies to understand viral entry, proviral integration, and expression of the viral protein Tax. however, the level of MHC class I remained unchanged. We performed kinetic studies to understand viral entry, proviral integration, and expression of the viral protein Tax. Multiplex cytokine profiling revealed production of an array of proinflammatory cytokines and type 1 IFN (IFN-) by FL-DCs treated with virus. Virus-matured FL-DCs stimulated proliferation of autologous CD3+T cells as shown by intracellular nuclear Ki67 staining and produced IFN- when cultured with infected FL-DCs. Gene expression studies using type 1 IFN-specific and DC-specific arrays revealed upregulation of IFN-stimulated genes, most cytokines, and transcription factors, but Pimecrolimus a distinct downregulation of many chemokines. Overall, these results highlight the critical early responses generated by FL-DCs on challenge with cell-free chimeric HTLV-1. Human T cell leukemia virus type 1 (HTLV-1) has infected 1020 million people worldwide (1). It is endemic in Japan, the Rabbit polyclonal to Vitamin K-dependent protein S Caribbean, parts of South America, and Central Africa. A majority of infected individuals remain asymptomatic carriers; only a small percentage (<5%) experience development of the disease (13). Why the disease develops in some infected individuals whereas others remain healthy carriers remains unknown. Causative studies have linked HTLV-1 with two predominant, immunologically distinct diseases: oncogenic adult T cell leukemia (ATL) (4) and the neuroinflammatory HTLV-1associated myelopathy/tropical spastic paraparesis (HAM/TSP) (5,6), as well as with many different clinical syndromes (7). It is believed that age and route of primary infection play a role in determining the clinical outcome after infection with HTLV-1. Studies have suggested that the risk for development of HAM/TSP is greater if HTLV-1 infection is acquired during adulthood, especially through sexual transmission (8), whereas individuals infected early in life through breast-feeding are believed to be at greater risk for ATL because the infected immature thymocytes have more chances to develop into malignant cells (9). The i.v. route of viral transmission has a predisposition to lead to the neurologic disease associated with the hyperimmune response, as was shown with a cohort of HAM patients, most of whom received blood transfusions (10). On the contrary, rats orally inoculated with HTLV-1 developed persistent infection, immune unresponsiveness, and T cell lymphomas (11,12), suggesting that mucosal exposure may lead to ATL. Viruses, like other pathogens, exhibit a variety of pathogen-associated molecular patterns such as RNA replication intermediates with genomic modifications, high repetition of capsomers on the surfaces of virions, and others that are recognized by pattern recognition receptors on various APCs such as dendritic cells (DCs). The ability of DCs to respond to the viral threat through an array Pimecrolimus of defense mechanisms makes their role critical in thwarting viral attacks. DCs are not only potent activators of CD8+and CD4+T cells, but they release a plethora of cytokines that serve an important role in determining the phenotype of Th cells and the eventual immunologic response. In addition, DCs are the key producers of the type 1 IFNs that are one of the early key antiviral cytokines released that can create an overall antiviral state through the activation of IFN-stimulated genes (ISGs). DCs behave and respond in a contrastingly different manner in the two immunologically distinct and diverse HTLV-1associated diseases, ATL and HAM/TSP. In the immunosuppressive ATL, the DCs fail to mature (1315); however, during hyperinflammatory HAM/TSP, the DCs mature rapidly (16). Thus, the DCs play an important role in two disparate disease states. HTLV-1 infection of DCs has been demonstrated in patients with HAM/TSP (17), as well as in vitro (16,18,19). In addition, autologously infected DCs, as well as those pulsed with inactivated HTLV-1 virions, can lead to a strong proliferative response of both CD4+and CD8+T cells (20). The route of viral exposure (mucosal versus peripheral blood) is believed to have an important bearing on the eventual outcome of the disease and warrants attention, considering the fact that different subsets of DCs are known to reside in these exclusively separate compartments. The mucosal route may be linked to the development of ATL (12), whereas peripheral blood exposure has been associated with HAM/TSP (10). Although the mucosa is enriched with unique DC subsets that sample pathogens in the gut and local area (2123), the peripheral blood is enriched predominantly with the viral-sensing, type I IFN-producing plasmacytoid DCs (pDCs) (24). Another level of complexity is the mode of viral delivery: cell free versus cell associated. Viruses may enter the cell through an array of different mechanisms, such as receptor-dependent and -independent endocytosis, pinocytosis, phagocytosis, as well as lipid raft-mediated endocytosis (25). Therefore, depending on Pimecrolimus the route of entry, different pattern recognition receptors maybe triggered, thereby eliciting different responses. In this respect, it was recently shown that cell-free virus can induce the production of IFN- from pDCs in a TLR7-dependent manner (26). Thus, we Pimecrolimus believe that the two distinct compartmental subsets of DCs may respond.